CHOOLIP & SCIENCES Inc. Share Price

A291650

KR7291650000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 14/08/2026			5-day change	1st Jan Change
1,676.00 ^KRW	-2.33%		-11.79%	+10.55%

14/04	Aptamer Sciences Inc announced that it has received KRW 30.00043989 billion in funding from Alticast Corporation, Daihyun Eng & Const Co., Ltd., K&P Investment Co., Ltd., Vision 2 Co., Ltd., JDK Partners Co., Ltd. and other investors.	CI
09/04	Aptamer Sciences Inc announced that it has received KRW 12 billion in funding	CI

Chart: CHOOLIP & SCIENCES Inc.

Dynamic Chart

Latest news : CHOOLIP & SCIENCES Inc.

14/04	Aptamer Sciences Inc announced that it has received KRW 30.00043989 billion in funding from Alticast Corporation, Daihyun Eng & Const Co., Ltd., K&P Investment Co., Ltd., Vision 2 Co., Ltd., JDK Partners Co., Ltd. and other investors.	CI
09/04	Aptamer Sciences Inc announced that it has received KRW 12 billion in funding	CI
25/03	Aptamer Sciences Inc agreed to acquire Choolip Inc. from Wellnew & Co for $11.4 million.	CI
12/02	Aptamer Sciences Inc announced that it has received KRW 7 billion in funding	CI
10/02	FOCUS AI Co., Ltd. announced that it has received KRW 5.423916904 billion in funding from Aptamer Sciences Inc, Nex Plan Co., Ltd., 3S E&D Co., Ltd.	CI
28/01	Aptamer Sciences Inc announced that it expects to receive KRW 12 billion in funding	CI
26/01	FOCUS AI Co., Ltd. announced that it has received KRW 999.999944 million in funding from Aptamer Sciences Inc	CI
16/01	Aptamer Sciences Inc announced that it expects to receive KRW 7 billion in funding from Bellum Fund 1	CI
19/12	FOCUS AI Co., Ltd. announced that it expects to receive KRW 999.999944 million in funding from Aptamer Sciences Inc	CI
03/12	FOCUS AI Co., Ltd. announced that it expects to receive KRW 9.42391668 billion in funding from Aptamer Sciences Inc and other investors	CI
24/25/24	Alticast Corporation completed the acquisition of 8.07% stake in Aptamer Sciences Inc from Han Dong-il, Ryu Seong-ho, Jang Seung-gi.	CI
08/25/08	Alticast Corporation agreed to acquire an 8.07% stake in Aptamer Sciences Inc from Han Dong-il, Ryu Seong-ho, Jang Seung-gi for KRW 4.4 billion.	CI
20/25/20	Aptamer Sciences wins 320 million won order	RE

More news

Managers and Directors: CHOOLIP & SCIENCES Inc.

Manager	Title	Age	Since
Jib-Hun Jeong CEO	Chief Executive Officer	54	27/10/2025
Seong-Su Kim DFI	Director of Finance/CFO	56	27/10/2025
Dae-Gyeon Lee CTO	Chief Tech/Sci/R&D Officer	53	-

Director	Title	Age	Since
Jib-Hun Jeong BRD	Director/Board Member	54	27/10/2025
Seong-Su Kim BRD	Director/Board Member	56	27/10/2025
In-Hyeon Lee BRD	Director/Board Member	51	27/10/2025

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CHOOLIP & SCIENCES INC.	-2.33%	-11.79%	-	-	3.62Cr
Average	-2.33%
Weighted average by Cap.	-2.33%

See all sector performances

CHOOLIP & SCIENCES Inc, formerly Aptamer Sciences Inc., is a Korea-based company engaged in the research and development of bio therapeutic drugs business. The Company mainly engaged in the provision of contract research organization (CRO) services for conducting biopharmaceutical analysis. In addition, the Company is engaged in the provision of oligonucleotide synthesis and aptamer discovery services, developing biopharmaceuticals such as insulin receptors, and conducting distribution and sales of consumer goods and health-related consumer products.

Employees

Sector

Biotechnology & Medical Research

More about the company